Cover Image
Market Research Report

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 646091
Published Content info 109 Pages
Delivery time: 1-2 business days
Price
Back to Top
Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018
Published: June 14, 2018 Content info: 109 Pages
Description

GlobalData's Medical Devices sector report, "Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0581EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview 7

3 Products under Development 8

  • 3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
  • 3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
  • 3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
  • 3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
  • 3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12

4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies 13

  • 4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 13
  • 4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 14

5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview 15

  • 5.1 Andramed GmbH Company Overview 15
  • 5.2 Boston Scientific Corp Company Overview 16
  • 5.3 C. R. Bard Inc Company Overview 18
  • 5.4 Cagent Vascular LLC Company Overview 21
  • 5.5 Contego Medical, LLC Company Overview 22
  • 5.6 Hexacath SA Company Overview 24
  • 5.7 Medtronic plc Company Overview 25
  • 5.8 MicroPort Scientific Corp Company Overview 26
  • 5.9 Minnesota Health Solutions Corporation Company Overview 28
  • 5.10 NuVascular Technologies Inc Company Overview 29
  • 5.11 QT Vascular Ltd Company Overview 30
  • 5.12 SurModics Inc Company Overview 31
  • 5.13 Terumo Corp Company Overview 34
  • 5.14 Terumo Europe NV Company Overview 35

6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments 38

  • 6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 38
  • 6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 40
  • 6.3 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 40
  • 6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 41
  • 6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 41
  • 6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 42
  • 6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 43
  • 6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results 43
  • 6.9 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 46
  • 6.10 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 47
  • 6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 48
  • 6.12 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 50
  • 6.13 Apr 23, 2018: Surmodics Announces FDA Clearance of a New .018" Low-Profile PTA Balloon Dilation Catheter 51
  • 6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 52
  • 6.15 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 52
  • 6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 53
  • 6.17 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 54
  • 6.18 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 56
  • 6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 56
  • 6.20 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 58
  • 6.21 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 59
  • 6.22 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 59
  • 6.23 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 61
  • 6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 63
  • 6.25 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 63
  • 6.26 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 64
  • 6.27 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 66
  • 6.28 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 66
  • 6.29 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 67
  • 6.30 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 68
  • 6.31 Dec 22, 2017: Kaneka releasing a high-pressure balloon catheter to enlarge peripheral vessels 68
  • 6.32 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 69
  • 6.33 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 70
  • 6.34 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 70
  • 6.35 Dec 04, 2017: Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval 72
  • 6.36 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 72
  • 6.37 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 75
  • 6.38 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 76
  • 6.39 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 77
  • 6.40 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 78
  • 6.41 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 80
  • 6.42 Oct 25, 2017: Bard Announces Third Quarter Results 81
  • 6.43 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 83
  • 6.44 Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 84
  • 6.45 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 84
  • 6.46 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 85
  • 6.47 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 86
  • 6.48 Oct 02, 2017: STENTYS: 2017 half-year results 87
  • 6.49 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 88
  • 6.50 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 88
  • 6.51 Sep 18, 2017: Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter 89
  • 6.52 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 90
  • 6.53 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 91
  • 6.54 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 94
  • 6.55 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 94
  • 6.56 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 95
  • 6.57 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 97
  • 6.58 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 97
  • 6.59 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 99
  • 6.60 Jul 24, 2017: Reewarm Gains CFDA Approval 100
  • 6.61 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 101
  • 6.62 Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 101
  • 6.63 Jul 07, 2017: MPSC New COO Glendy Wang on Board 102
  • 6.64 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 102
  • 6.65 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 104

7 Appendix 106

  • 7.1 Methodology 106
  • 7.2 About GlobalData 109
  • 7.3 Contact Us 109
  • 7.4 Disclaimer 109

List of Tables

1.1 List of Tables

  • Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
  • Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
  • Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
  • Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
  • Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12
  • Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 13
  • Table 7: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 14
  • Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: Zero-Profile PTA Balloon - Product Status 15
  • Table 10: Zero-Profile PTA Balloon - Product Description 15
  • Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 12: Drug Coated Balloon - Below-The-Knee (BTK) - Product Status 16
  • Table 13: Drug Coated Balloon - Below-The-Knee (BTK) - Product Description 16
  • Table 14: Next Generation 0.018" Balloon - Product Status 17
  • Table 15: Next Generation 0.018" Balloon - Product Description 17
  • Table 16: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 17: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Status 18
  • Table 18: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Description 18
  • Table 19: C. R. Bard Inc - Ongoing Clinical Trials Overview 19
  • Table 20: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions 20
  • Table 21: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 22: Serranator Bass - Product Status 21
  • Table 23: Serranator Bass - Product Description 21
  • Table 24: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 25: PALADIN - Product Status 22
  • Table 26: PALADIN - Product Description 22
  • Table 27: Superficial Femoral Artery Balloon - Product Status 23
  • Table 28: Superficial Femoral Artery Balloon - Product Description 23
  • Table 29: Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 30: MERAK PTA Dilatation Catheter - Product Status 24
  • Table 31: MERAK PTA Dilatation Catheter - Product Description 24
  • Table 32: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 33: Chocolate PTA Balloon Catheter - Product Status 25
  • Table 34: Chocolate PTA Balloon Catheter - Product Description 25
  • Table 35: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 36: Reewarm14 - Product Status 26
  • Table 37: Reewarm14 - Product Description 26
  • Table 38: Reewarm18 Peripheral Balloon Dilation Catheter - Product Status 27
  • Table 39: Reewarm18 Peripheral Balloon Dilation Catheter - Product Description 27
  • Table 40: Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 41: Balloon Angioplasty Inflation Device - Product Status 28
  • Table 42: Balloon Angioplasty Inflation Device - Product Description 28
  • Table 43: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 44: NuSpun DE Balloon - Product Status 29
  • Table 45: NuSpun DE Balloon - Product Description 29
  • Table 46: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 47: Silk PTA Balloon Catheter - Product Status 30
  • Table 48: Silk PTA Balloon Catheter - Product Description 30
  • Table 49: SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 50: 0.018" OTW Dual Lumen PTA Catheter - Product Status 31
  • Table 51: 0.018" OTW Dual Lumen PTA Catheter - Product Description 31
  • Table 52: 0.018" RX Dual Lumen PTA Catheter - Product Status 32
  • Table 53: 0.018" RX Dual Lumen PTA Catheter - Product Description 32
  • Table 54: 0.035" Large Diameter OTW PTA Catheter - Product Status 32
  • Table 55: 0.035" Large Diameter OTW PTA Catheter - Product Description 33
  • Table 56: 0.035" Next Generation Workhorse PTA Catheter - Product Status 33
  • Table 57: 0.035" Next Generation Workhorse PTA Catheter - Product Description 33
  • Table 58: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 59: TRI PTA Balloon - Product Status 34
  • Table 60: TRI PTA Balloon - Product Description 34
  • Table 61: Terumo Europe NV Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 62: Kanshas Drug Coated Balloon - Product Status 35
  • Table 63: Kanshas Drug Coated Balloon - Product Description 35
  • Table 64: Terumo Europe NV - Ongoing Clinical Trials Overview 36
  • Table 65: Kanshas Drug Coated Balloon - Prospective, Multi-Center, Open, Single Arm Study for the Treatment of Patients Presenting De Novo Lesions in the Superficial Femoral or Popliteal Arteries Using a Kanshas Drug Coated Balloon Catheter 37
  • Table 66: Glossary 108

List of Figures

1.2 List of Figures

  • Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
  • Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
  • Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
  • Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
  • Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12
Back to Top